Background: Despite the crucial role played by general practitioners in the identification and care of people with cognitive impairment, few data are available on how they may improve the early recognition of patients with Alzheimer dementia (AD), especially those with long (i.e., 10 years and longer) medical history. Aims: To investigate the occurrence and the predictors of AD during a 10-year or longer period prior AD diagnosis in primary care patients aged 60 years or older. Materials and Methods: A cohort study with a nested case-control analysis has been conducted. Data were extracted from the Italian Health Search Database (HSD), an Italian database with primary care data. AD cases have been defined in accordance with the International Classification of Diseases, ninth edition (ICD-9-CM) codes and coupled with the use of anti-dementia drugs. Prevalence and incidence rates of AD have been calculated. To test the association between candidate predictors, being identified in a minimum period of 10 years, and incident cases of AD, we used a multivariate conditional logistic regression model. Results: As recorded in the primary care database, AD prevalence among patients aged 60 years or older was 0.8% during 2016, reaching 2.4% among nonagenarians. Overall, 1,889 incident cases of AD have been identified, with an incidence rate as high as 0.09% person-year. Compared with 18,890 matched controls, history of hallucinations, agitation, anxiety, aberrant motor behavior, and memory deficits were positively associated with higher odds of AD (p < 0.001 for all) diagnosis. A previous diagnosis of depression and diabetes and the use of low-dose aspirin and non-steroidal anti-inflammatory drugs were associated with higher odds of AD (p < 0.05 for all). Conclusion: Our findings show that, in accordance with primary care records, 1% of patients aged 60 years and older have a diagnosis of AD, with an incident AD diagnosis of 0.1% per year. AD is often under-reported in primary care settings; yet, several predictors identified in this study may support general practitioners to early identify patients at risk of AD.

1.
Grande
G
,
Qiu
C
,
Fratiglioni
L
.
Prevention of dementia in an ageing world: evidence and biological rationale
.
Ageing Res Rev
.
2020 Mar 19
:
101045
. .
2.
Winblad
B
,
Amouyel
P
,
Andrieu
S
,
Ballard
C
,
Brayne
C
,
Brodaty
H
, et al
Defeating Alzheimer’s disease and other dementias: a priority for European science and society
.
Lancet Neurol
.
2016 Apr
;
15
(
5
):
455
532
. .
3.
Sauvaget
C
,
Yamada
M
,
Fujiwara
S
,
Sasaki
H
,
Mimori
Y
.
Dementia as a predictor of functional disability: a four-year follow-up study
.
Gerontology
.
2002 Jul-Aug
;
48
(
4
):
226
33
. .
4.
Strand
BH
,
Knapskog
AB
,
Persson
K
,
Edwin
TH
,
Amland
R
,
Mjørud
M
, et al
Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway
.
PLoS One
.
2018
;
13
(
9
):
e0204436
. .
5.
Zhu
CW
,
Scarmeas
N
,
Ornstein
K
,
Albert
M
,
Brandt
J
,
Blacker
D
, et al
Health-care use and cost in dementia caregivers: longitudinal results from the Predictors Caregiver Study
.
Alzheimers Dement
.
2015 Apr
;
11
(
4
):
444
54
. .
6.
O’Shea
E
,
Hopper
L
,
Marques
M
,
Gonçalves-Pereira
M
,
Woods
B
,
Jelley
H
, et al
A comparison of self and proxy quality of life ratings for people with dementia and their carers: a European prospective cohort study
.
Aging Ment Health
.
2020 Jan
;
24
(
1
):
162
70
. .
7.
Grande
G
,
Tramacere
I
,
Vetrano
DL
,
Clerici
F
,
Pomati
S
,
Mariani
C
, et al
Role of anticholinergic burden in primary care patients with first cognitive complaints
.
Eur J Neurol
.
2017 Jul
;
24
(
7
):
950
5
. .
8.
Walters
K
,
Hardoon
S
,
Petersen
I
,
Iliffe
S
,
Omar
RZ
,
Nazareth
I
, et al
Predicting dementia risk in primary care: development and validation of the Dementia Risk Score using routinely collected data
.
BMC Med
.
2016 Jan 21
;
14
:
6
. .
9.
Glaudemans
JJ
,
Moll van Charante
E
,
Wind
J
,
Oosterink
JJ
,
Willems
DL
.
Experiences with approaches to advance care planning with older people: a qualitative study among Dutch general practitioners
.
BMJ Open
.
2018 Nov 25
;
8
(
11
):
e024762
. .
10.
Ju
I
,
Banks
E
,
Calabria
B
,
Ju
A
,
Agostino
J
,
Korda
RJ
, et al
General practitioners’ perspectives on the prevention of cardiovascular disease: systematic review and thematic synthesis of qualitative studies
.
BMJ Open
.
2018 Nov 1
;
8
(
11
):
e021137
. .
11.
Rhee
JJ
,
Teo
PCK
,
Mitchell
GK
,
Senior
HE
,
Tan
AJH
,
Clayton
JM
.
General practitioners (GPs) and end-of-life care: a qualitative study of Australian GPs and specialist palliative care clinicians
.
BMJ Support Palliat Care
.
2018 [Online ahead of print]
.
12.
Guglielmi
V
,
Bellia
A
,
Pecchioli
S
,
Della-Morte
D
,
Parretti
D
,
Cricelli
I
, et al
Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: a real-world evidence study in primary care
.
Atherosclerosis
.
2017 Aug
;
263
:
36
41
. .
13.
Vetrano
DL
,
Bianchini
E
,
Onder
G
,
Cricelli
I
,
Cricelli
C
,
Bernabei
R
, et al
Poor adherence to chronic obstructive pulmonary disease medications in primary care: role of age, disease burden and polypharmacy
.
Geriatr Gerontol Int
.
2017 Dec
;
17
(
12
):
2500
6
. .
14.
Marconi
E
,
Bettiol
A
,
Lombardi
N
,
Crescioli
G
,
Parretti
L
,
Vannacci
A
, et al
Prescribing patterns of allopurinol and febuxostat according to directives on the reimbursement criteria and clinical guidelines: analysis of a primary care database
.
Curr Med Res Opin
.
2019 Apr
;
35
(
4
):
683
8
. .
15.
Breslow
NE
.
Statistics in epidemiology: the case-control study
.
J Am Stat Assoc
.
1996 Mar
;
91
(
433
):
14
28
. .
16.
Luck
T
,
Riedel-Heller
SG
,
Kaduszkiewicz
H
,
Bickel
H
,
Jessen
F
,
Pentzek
M
, et al
Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe)
.
Dement Geriatr Cogn Disord
.
2007
;
24
(
4
):
307
16
. .
17.
Martin
E
,
Velayudhan
L
.
Neuropsychiatric symptoms in mild cognitive impairment: a literature review
.
Dement Geriatr Cogn Disord
.
2020
;
49
(
2
):
146
55
. .
18.
Dotson
VM
,
Beydoun
MA
,
Zonderman
AB
.
Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment
.
Neurology
.
2010 Jul 6
;
75
(
1
):
27
34
. .
19.
Brommelhoff
JA
,
Gatz
M
,
Johansson
B
,
McArdle
JJ
,
Fratiglioni
L
,
Pedersen
NL
.
Depression as a risk factor or prodromal feature for dementia? Findings in a population-based sample of Swedish twins
.
Psychol Aging
.
2009 Jun
;
24
(
2
):
373
84
. .
20.
Singh-Manoux
A
,
Dugravot
A
,
Fournier
A
,
Abell
J
,
Ebmeier
K
,
Kivimäki
M
, et al
Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study
.
JAMA Psychiatry
.
2017 Jul 1
;
74
(
7
):
712
8
. .
21.
Enache
D
,
Winblad
B
,
Aarsland
D
.
Depression in dementia: epidemiology, mechanisms, and treatment
.
Curr Opin Psychiatry
.
2011 Nov
;
24
(
6
):
461
72
. .
22.
Qiu
C
,
Fratiglioni
L
.
A major role for cardiovascular burden in age-related cognitive decline
.
Nat Rev Cardiol
.
2015 May
;
12
(
5
):
267
77
. .
23.
Biessels
GJ
,
Staekenborg
S
,
Brunner
E
,
Brayne
C
,
Scheltens
P
.
Risk of dementia in diabetes mellitus: a systematic review
.
Lancet Neurol
.
2006 Jan
;
5
(
1
):
64
74
. .
24.
Shang
Y
,
Fratiglioni
L
,
Marseglia
A
,
Plym
A
,
Welmer
AK
,
Wang
HX
, et al
Association of diabetes with stroke and post-stroke dementia: a population-based cohort study
.
Alzheimers Dement
.
2020 Jul
;
16
(
7
):
1003
12
.
25.
Yaffe
K
,
Blackwell
T
,
Kanaya
AM
,
Davidowitz
N
,
Barrett-Connor
E
,
Krueger
K
.
Diabetes, impaired fasting glucose, and development of cognitive impairment in older women
.
Neurology
.
2004 Aug 24
;
63
(
4
):
658
63
. .
26.
Szekely
CA
,
Green
RC
,
Breitner
JC
,
Østbye
T
,
Beiser
AS
,
Corrada
MM
, et al
No advantage of a beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies
.
Neurology
.
2008 Jun 10
;
70
(
24
):
2291
8
. .
27.
Drummond
N
,
Birtwhistle
R
,
Williamson
T
,
Khan
S
,
Garies
S
,
Molnar
F
.
Prevalence and management of dementia in primary care practices with electronic medical records: a report from the Canadian primary care sentinel surveillance network
.
CMAJ Open
.
2016 Apr-Jun
;
4
(
2
):
E177
84
. .
28.
Cova
I
,
Markova
A
,
Campini
I
,
Grande
G
,
Mariani
C
,
Pomati
S
.
Worldwide trends in the prevalence of dementia
.
J Neurol Sci
.
2017 Aug 15
;
379
:
259
60
. .
29.
Perera
G
,
Pedersen
L
,
Ansel
D
,
Alexander
M
,
Arrighi
HM
,
Avillach
P
, et al
Dementia prevalence and incidence in a federation of European electronic health record databases: the European medical informatics framework resource
.
Alzheimers Dement
.
2018 Feb
;
14
(
2
):
130
9
. .
30.
van Bussel
EF
,
Richard
E
,
Arts
DL
,
Nooyens
AC
,
Coloma
PM
,
de Waal
MW
, et al
Dementia incidence trend over 1992-2014 in the Netherlands: analysis of primary care data
.
PLoS Med
.
2017 Mar
;
14
(
3
):
e1002235
. .
31.
Callahan
CM
,
Hendrie
HC
,
Tierney
WM
.
Documentation and evaluation of cognitive impairment in elderly primary care patients
.
Ann Intern Med
.
1995 Mar 15
;
122
(
6
):
422
9
. .
32.
Valcour
VG
,
Masaki
KH
,
Curb
JD
,
Blanchette
PL
.
The detection of dementia in the primary care setting
.
Arch Intern Med
.
2000 Oct 23
;
160
(
19
):
2964
8
. .
33.
Sommerlad
A
,
Perera
G
,
Singh-Manoux
A
,
Lewis
G
,
Stewart
R
,
Livingston
G
.
Accuracy of general hospital dementia diagnoses in England: sensitivity, specificity, and predictors of diagnostic accuracy 2008–2016
.
Alzheimers Dement
.
2018 Jul
;
14
(
7
):
933
43
. .
34.
Olafsdottir
M
,
Skoog
I
,
Marcusson
J
.
Detection of dementia in primary care: the Linkoping study
.
Dement Geriatr Cogn Disord
.
2000 Jul–Aug
;
11
(
4
):
223
9
.
35.
Rizzuto
D
,
Feldman
AL
,
Karlsson
IK
,
Dahl Aslan
AK
,
Gatz
M
,
Pedersen
NL
.
Detection of dementia cases in two Swedish health registers: a validation study
.
J Alzheimers Dis
.
2018
;
61
(
4
):
1301
10
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.